Atomoxetine Allergy Management

Introduction to Atomoxetine Metabolism

• Atomoxetine is primarily metabolized through the cytochrome P450 2D6 (CYP2D6) pathway, and other medications using this pathway should be used with caution 1

Medications to Avoid with Atomoxetine Allergy

• Patients with a confirmed atomoxetine allergy should avoid other norepinephrine reuptake inhibitors, such as Reboxetine and Viloxazine, as well as certain SNRIs with similar chemical structures 1
• Monoamine Oxidase Inhibitors (MAOIs), including Phenelzine, Isocarboxazid, Moclobemide, Isoniazid, and Linezolid, can interact with noradrenergic agents and potentially cause serious reactions, including hyperthermia, rigidity, myoclonus, and autonomic instability 2

Alternative Treatments for ADHD

• The American Academy of Child and Adolescent Psychiatry recommends considering alternative treatments for ADHD, such as stimulants (if no cross-reactivity concerns) or non-stimulant options like Clonidine, Guanfacine, or Bupropion 3
• Methylphenidate-based medications have different chemical structures than atomoxetine and may be safe alternatives for ADHD treatment 3

Patient Safety and Documentation

• True allergic reactions involve immune system activation and can be life-threatening, whereas side effects are not allergic reactions 4
• The atomoxetine allergy should be clearly documented in all medical records and pharmacy profiles to prevent accidental re-exposure 3
• If the patient is pregnant, atomoxetine does not seem to be associated with major congenital malformations or other significant adverse obstetrical outcomes, but data are limited 3